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is ii synthetic organoselenium compound with anti-inflammatory activity ( I . 21 , which exhibits glutathione peroxidase (GSH-Px)-like activity, catalysing the reduction of hydrogen peroxide as well as other organic peroxides [3] [4] [5] . Its antiinflammatory effect may be mediated by either the GSH-Px activity, the inhibition of leukotriene B4 formation [6] , the antioxidant capacity, or a combination of all of them. Many attempts have been made to increase the antioxidant capacity of the myocardium, since free radical generation has been demonstrated in ischaemia-reperfusion damage [7, 81; superoxide dismutase (SOD) and catalase have been used to decrease myocardial reperfusion injury [9] . Moreover, glutathione (GSH) decreases in the myocardium under ischaemic conditions [ 101 and a possible involvement of the myocardial mitochondria1 pool of GSH has also been recently discussed ( I 1 1. This evidence and hypothesis led us to investigate some aspects of the cardiac antioxidant defence, as well as the effect of Ebselen treatment on the peroxidase activity of the myocardium, which are preliminary results necessary for a rationale of the use of Ebselen to prevent or ameliorate ischaemic or reperfusion damage.
Muterials and methods
Wistar rats weighing 240-260 g which were fed a standard laboratory diet and with free access to water were used for the experiments. Ebselen was administered intraperitoneally at a dose of 40 mg/kg body weight, as an olive oil suspension, where controls received the appropriate amount of oil. All animals were sacrificed 2 h after injection since the highest plasma concentration of total selenium after oral administration of 77Se-Ebselen to a healthy volunteer has been reported at this time [12] . Hearts were homogenized in 0.1 M potassium phosphate buffer pH 7.0, and the enzymic activities and protein content determinations done o n the cytosolic fraction ( 100 000 g supernatant). In order to Ahhreviations used: Ebselen, 2-phen yl-I ,2-benzisoelenazol-3-(,?H)-one: GSH, glutathione; GSH-Px, glutathione peroxidase; SOD, superoxide dismutase; CDNB, 1 -chlor-2,4-dinitrobenzene.
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determine the Ebselen-dependent GSH-Px-like activity, hearts were homogenized in 2% perchloric acid containing 1 mM EDTA, and the peroxidase activity studied in the neutralized supernatant. Different animals were used for these purposes t o minimize the further biotransformation o f Ebselen in the fresh cardiac homogenate [ 131. GSH-Px activity [ 141, using HzOz and t-butylhydroperoxide, glutathione S-transferase activity, using 1-chlor-2,J-dinitroben- Results urid disciission Table 1 shows the activity of different antioxidant and glutathione-related enzymic activity o f the rat heart in control conditions. The enzymic activities tested in control myocardium are directly or indirectly related to the antioxidant defence, i.e. by either reducing the activated oxygen species formed (SOD, GSH-Px). maintaining the reduced state of the substrates of the previous enzymes (glutathione reductase), preventing the redox cycling of different quinones (DT-diaphorase), or conjugating xenobiotics [ 15 I or toxic products of lipid peroxidation [ 161 (glutathione S-transferases). The importance of these enzymic activities in the myocardium has been discussed, with regard to the cardiac toxicity of different quinones (2 1 ] and the conjugation of the toxic product of lipid peroxidation (221 in myocardium [23] . Table 1 also shows the GSH-Px activity in the myocardial cytosolic fraction of rats treated intraperitoneally with 40 mg/kg Ebselen. A significant increase in peroxidase activity was found in the cytosolic fraction of hearts treated with Ebselen. To elucidate whether this increase was due to an effect of Ebselen or the Se derived from it on the GSH-Px of the heart, and not to a direct increase due to the myocardial tissue content of Ebselen itself or any of its metabolites, Ebselen-dependent GSH-Px-like activity was determined in the acid extract. It is not possible to establish if this activity observed in the neutralized acid extract of the heart is dependent on unmodified Ebselen, or if any of the hepatic metabolites [ 131 retains some GSH-Px-like activity and may also accumulate in the myocardium. In any case, there is an effective increase in the myocardial GSH-Px activity 2 h after Ebselen treatment. These results are of interest since the heart might become the target of different Table 1 . Antioxidant and some GSH-related enzymic activities in myocardial cytosolic fiaction of control rat heart and the effect of Ebselen treatment (40 rnglkg body weight) on the GSH-Px activity of the cytosol and the recovery of Ebselen-dependent GSH-I'x activity in the acid extract of the heart 
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